Mersana Therapeutics, Inc. Deferred Revenue
Mersana Therapeutics, Inc. had Deferred Revenue of $21.64 million as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-03-28
- 2017-12-31: Deferred Revenue, Current $21.64M.
- 2017-09-30: Deferred Revenue, Current $16.48M.
- 2017-06-30: Deferred Revenue, Current $24.87M.
- 2016-12-31: Deferred Revenue, Current $22.73M; Deferred Revenue, Current as first filed $22.73M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2017-12-31 | $21.64M 10-K · filed 2018-03-28 | |
| 2017-09-30 | $16.48M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $24.87M 10-Q · filed 2017-08-11 | |
| 2016-12-31 | $22.73M 10-K · filed 2018-03-28 | $22.73M 10-Q · filed 2017-08-11 |